Modulation of dendritic cell differentiation and maturation by decoy receptor 3

被引：102

作者：

Hsu, TL

Chang, YC

Chen, SJ

Liu, YJ

Chiu, AW

Chio, CC

Chen, LP

Hsieh, SL ^{[1
]}

机构：

[1] Natl Yang Ming Univ, Dept Microbiol & Immunol, Taipei 112, Taiwan

[2] Natl Yang Ming Univ, Immunol Res Ctr, Taipei 112, Taiwan

[3] Chi Mei Foundat Hosp, Tainan, Taiwan

[4] Mayo Clin & Mayo Grad Sch Med, Dept Immunol, Rochester, MN 55905 USA

[5] DNAX Res Inst Mol & Cellular Biol Inc, Dept Immunobiol, Palo Alto, CA 94304 USA

来源：

JOURNAL OF IMMUNOLOGY | 2002年 / 168卷 / 10期

关键词：

D O I：

10.4049/jimmunol.168.10.4846

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Decoy receptor 3 (DcR3), a soluble receptor belonging to the TNFR superfamily, is a receptor for both Fas ligand (FasL) and LIGHT. It has been demonstrated that DcR3 is up-regulated in lung and colon cancers, thus promoting tumor growth by neutralizing the cytotoxic effects of FasL and LIGHT. In this study, we found that DcR3.Fc profoundly modulated dendritic cell differentiation and maturation from CD14(+) monocytes, including the up-regulation of CD86/B7.2, and the down-regulation of CD40, CD54/ICAM-1, CD80/B7.1, CD1a, and HLA-DR. Moreover, DcR3-treated dendritic cells suppressed CD4(+) T cell proliferation in an allogeneic MLR and up-regulated IL-4 secretion of CD4(+)CD45RA(+) T cells. This suggests that DcR3.Fc may act not only as a decoy receptor to FasL and LIGHT, but also as an effector molecule to skew T cell response to the Th2 phenotype.

引用

收藏

页码：4846 / 4853

页数：8

相关论文

共 39 条

[11] B7-1 AND B7-2 DO NOT DELIVER IDENTICAL COSTIMULATORY SIGNALS, SINCE B7-2 BUT NOT B7-1 PREFERENTIALLY COSTIMULATES THE INITIAL PRODUCTION OF IL-4 [J].

FREEMAN, GJ ;

BOUSSIOTIS, VA ;

ANUMANTHAN, A ;

BERNSTEIN, GM ;

KE, XY ;

RENNERT, PD ;

GRAY, GS ;

GRIBBEN, JG ;

NADLER, LM .

IMMUNITY, 1995, 2 (05) :523-532

[12] Breast cancer-associated antigen, DF3/MUC1, induces apoptosis of activated human T cells [J].

Gimmi, CD ;

Morrison, BW ;

Mainprice, BA ;

Gribben, JG ;

Boussiotis, VA ;

Freeman, GJ ;

Park, SYL ;

Watanabe, M ;

Gong, JL ;

Hayes, DF ;

Kufe, DW ;

Nadler, LM .

NATURE MEDICINE, 1996, 2 (12) :1367-1370

[13] B7-1 AND B7-2 COSTIMULATORY MOLECULES ACTIVATE DIFFERENTIALLY THE TH1/TH2 DEVELOPMENTAL PATHWAYS - APPLICATION TO AUTOIMMUNE-DISEASE THERAPY [J].

KUCHROO, VK ;

DAS, MP ;

BROWN, JA ;

RANGER, AM ;

ZAMVIL, SS ;

SOBEL, RA ;

WEINER, HL ;

NABAVI, N ;

GLIMCHER, LH .

CELL, 1995, 80 (05) :707-718

[14] CD137 induces proliferation and endomitosis in monocytes [J].

Langstein, J ;

Michel, J ;

Schwarz, H .

BLOOD, 1999, 94 (09) :3161-3168

[15] Aberrant expression and reverse signalling of CD70 on malignant B cells [J].

Lens, SMA ;

Drillenburg, P ;

den Drijver, BFA ;

van Schijndel, G ;

Pals, ST ;

van Lier, RAW ;

van Oers, MHJ .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) :491-503

[16] DIFFERENTIAL-EFFECTS OF ANTI-B7-1 AND ANTI-B7-2 MONOCLONAL-ANTIBODY TREATMENT ON THE DEVELOPMENT OF DIABETES IN THE NONOBESE DIABETIC MOUSE [J].

LENSCHOW, DJ ;

HO, SC ;

SATTAR, H ;

RHEE, L ;

GRAY, G ;

NABAVI, N ;

HEROLD, KC ;

BLUESTONE, JA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :1145-1155

[17] LIGHT, a new member of the TNF superfamily, and lymphotoxin α are ligands for herpesvirus entry mediator [J].

Mauri, DN ;

Ebner, R ;

Montgomery, RI ;

Kochel, KD ;

Cheung, TC ;

Yu, GL ;

Ruben, S ;

Murphy, M ;

Eisenberg, RJ ;

Cohen, GH ;

Spear, PG ;

Ware, CF .

IMMUNITY, 1998, 8 (01) :21-30

[18] Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1 [J].

Nakashima, M ;

Sonoda, K ;

Watanabe, T .

NATURE MEDICINE, 1999, 5 (08) :938-942

[19] Amplification and expression of a decoy receptor for Fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas [J].

Ohshima, K ;

Haraoka, S ;

Sugihara, M ;

Suzumiya, J ;

Kawasaki, C ;

Kanda, M ;

Kikuchi, M .

CANCER LETTERS, 2000, 160 (01) :89-97

[20]

Otsuki T, 2000, CLIN EXP IMMUNOL, V119, P323

← 1 2 3 4 →